RITAMIX(01936.HK)携手科鼎及马来西亚理工大学进行保健品研究
格隆汇 12 月 8日丨RITAMIX(01936.HK)公告,一间全资附属公司Kevon Sdn.Bhd.("Kevon"()其从事分销人类食品配料)致力于研发、制定、销售及分销烟醯胺单核苷酸("NMN")膳食补充剂,其亦称为抗衰老保健品。
公司与Bioalpha International Sdn.Bhd.("BISB"()科鼎控股有限公司("科鼎"),一间于马来西亚股票交易所上市的公司(股份代号:0179)全资附属公司)就BISB向中华人民共和国及东南亚(包括马来西亚)市场制造及供应NMN膳食补充剂订立合作协议。科鼎及集团亦将与马来西亚理工大学合作,以进行基于NMN的保健品的研究。
董事会认为,公司业务策略一为不时考虑有前景业务及投资机遇,藉此提升集团整体价值及公司股东利益。
董事会预计集团将从结合其于研发、制定、销售及推广的经验连同科鼎的抗衰老药品及保健品的制造背景中获益。董事会相信,合作将进一步丰富集团的保健品产品组合,符合公司及股东的整体最佳利益。
集团的首个内部产品为NAD+粉末袋装补充剂,亦称为"唐原堂",预期于2021年初进入马来西亚市场。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.